Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

18.86
Delayed Data
As of 3:59pm ET
 +0.49 / +2.67%
Today’s Change
11.41
Today|||52-Week Range
24.88
+53.71%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close18.37
Today’s open18.63
Day’s range18.38 - 18.91
Volume1,398,508
Average volume (3 months)1,788,862
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-14.94%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book31.94

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp+0.56+2.34%
JUNOJuno Therapeutics In...+1.03+4.33%
XONIntrexon Corp+0.10+0.50%
BLUEbluebird bio Inc+3.25+3.94%
Data as of 4:02pm ET, 04/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts


Search for Jobs